Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126250331 | 12625033 | 1 | I | 201605 | 20160718 | 20160805 | 20160805 | EXP | US-ASTRAZENECA-2016SE78152 | ASTRAZENECA | 66.00 | YR | F | Y | 72.60000 | KG | 20160805 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126250331 | 12625033 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 116880 | MG | 21153 | 40 | MG | QD | ||||||
126250331 | 12625033 | 2 | SS | LYRICA | PREGABALIN | 1 | Unknown | M38210 | 0 | 75 | MG | CAPSULE, HARD | TID | ||||||
126250331 | 12625033 | 3 | SS | LYRICA | PREGABALIN | 1 | Unknown | M38210 | 0 | 75 | MG | CAPSULE, HARD | TID | ||||||
126250331 | 12625033 | 4 | SS | LYRICA | PREGABALIN | 1 | Unknown | M38210 | 0 | 75 | MG | CAPSULE, HARD | TID | ||||||
126250331 | 12625033 | 5 | SS | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | CAPSULE, HARD | TID | |||||||
126250331 | 12625033 | 6 | SS | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | CAPSULE, HARD | TID | |||||||
126250331 | 12625033 | 7 | SS | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | CAPSULE, HARD | TID | |||||||
126250331 | 12625033 | 8 | SS | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | CAPSULE, HARD | TID | |||||||
126250331 | 12625033 | 9 | SS | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | CAPSULE, HARD | TID | |||||||
126250331 | 12625033 | 10 | SS | LYRICA | PREGABALIN | 1 | Unknown | 0 | 75 | MG | CAPSULE, HARD | TID | |||||||
126250331 | 12625033 | 11 | SS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, 1X/DAY (1 A DAY) (1 MORE DAILY) | 0 | ||||||||||
126250331 | 12625033 | 12 | SS | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | 0 | 160 | MG | QD | ||||||||
126250331 | 12625033 | 13 | SS | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | 0 | 160 | MG | QD | ||||||||
126250331 | 12625033 | 14 | SS | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | 0 | |||||||||||
126250331 | 12625033 | 15 | SS | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | 0 | |||||||||||
126250331 | 12625033 | 16 | SS | FISH OIL | FISH OIL | 1 | Unknown | 0 | 1000 | MG | BID | ||||||||
126250331 | 12625033 | 17 | SS | FISH OIL | FISH OIL | 1 | Unknown | 0 | 1000 | MG | BID | ||||||||
126250331 | 12625033 | 18 | SS | FISH OIL | FISH OIL | 1 | Unknown | 0 | |||||||||||
126250331 | 12625033 | 19 | SS | FISH OIL | FISH OIL | 1 | Unknown | 0 | |||||||||||
126250331 | 12625033 | 20 | C | KLONOPIN | CLONAZEPAM | 1 | UNK | 0 | |||||||||||
126250331 | 12625033 | 21 | C | KLONOPIN | CLONAZEPAM | 1 | 0 | 1 | MG | TID | |||||||||
126250331 | 12625033 | 22 | C | HYDROCODONE | HYDROCODONE | 1 | UNK | 0 | |||||||||||
126250331 | 12625033 | 23 | C | HYDROCODONE | HYDROCODONE | 1 | UNK | 0 | |||||||||||
126250331 | 12625033 | 24 | C | HYDROCODONE | HYDROCODONE | 1 | UNK (5-325-1-3 X DAY) | 0 | |||||||||||
126250331 | 12625033 | 25 | C | HYDROCODONE | HYDROCODONE | 1 | UNK (5-325-1-3 X DAY) | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126250331 | 12625033 | 1 | Gastrooesophageal reflux disease |
126250331 | 12625033 | 2 | Nerve injury |
126250331 | 12625033 | 3 | Neuralgia |
126250331 | 12625033 | 4 | Sciatica |
126250331 | 12625033 | 5 | Nerve injury |
126250331 | 12625033 | 6 | Neuralgia |
126250331 | 12625033 | 7 | Sciatica |
126250331 | 12625033 | 8 | Nerve injury |
126250331 | 12625033 | 9 | Neuralgia |
126250331 | 12625033 | 10 | Sciatica |
126250331 | 12625033 | 12 | Blood triglycerides |
126250331 | 12625033 | 13 | Blood cholesterol abnormal |
126250331 | 12625033 | 14 | Blood triglycerides |
126250331 | 12625033 | 15 | Blood cholesterol abnormal |
126250331 | 12625033 | 16 | Blood triglycerides |
126250331 | 12625033 | 17 | Blood cholesterol abnormal |
126250331 | 12625033 | 18 | Blood triglycerides |
126250331 | 12625033 | 19 | Blood cholesterol abnormal |
126250331 | 12625033 | 20 | Menopause |
126250331 | 12625033 | 21 | Menopause |
126250331 | 12625033 | 22 | Back pain |
126250331 | 12625033 | 23 | Sciatica |
126250331 | 12625033 | 24 | Back pain |
126250331 | 12625033 | 25 | Sciatica |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126250331 | 12625033 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126250331 | 12625033 | Dental caries | |
126250331 | 12625033 | Post procedural contusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126250331 | 12625033 | 1 | 2008 | 0 | ||
126250331 | 12625033 | 2 | 2003 | 0 | ||
126250331 | 12625033 | 3 | 2003 | 0 | ||
126250331 | 12625033 | 4 | 2003 | 0 | ||
126250331 | 12625033 | 5 | 20120302 | 0 | ||
126250331 | 12625033 | 6 | 20120302 | 0 | ||
126250331 | 12625033 | 7 | 20120302 | 0 | ||
126250331 | 12625033 | 8 | 201303 | 0 | ||
126250331 | 12625033 | 9 | 201303 | 0 | ||
126250331 | 12625033 | 10 | 201303 | 0 | ||
126250331 | 12625033 | 11 | 2014 | 0 | ||
126250331 | 12625033 | 12 | 2013 | 0 | ||
126250331 | 12625033 | 13 | 2013 | 0 | ||
126250331 | 12625033 | 16 | 2013 | 0 | ||
126250331 | 12625033 | 17 | 2013 | 0 | ||
126250331 | 12625033 | 20 | 1997 | 0 | ||
126250331 | 12625033 | 21 | 2014 | 0 | ||
126250331 | 12625033 | 22 | 2012 | 0 | ||
126250331 | 12625033 | 23 | 2012 | 0 |